NASDAQ

Marker Therapeutics, Inc. (MRKR)

♥ 591 Thanks from members

Live price chart, market sentiment, and community perspectives for Marker Therapeutics, Inc. (NASDAQ: MRKR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Johnathan M. GreenFounder: Ann LeenLeadership: Connor Kelley (CEO)Leadership: Ronald Brown (CFO)Holder: BlackRock, Inc.Holder: The Vanguard GroupHolder: Armistice CapitalMulti-antigen specific T cell therapiesMT-601MT-401#MRKR stock#Marker Therapeutics#T cell immunotherapy#cancer treatment biotech#NASDAQ biotechnology